Home/BlueWhale Bio/Carl H. June, MD

CH

Carl H. June, MD

Scientific Advisory Board

Therapeutic Areas

BlueWhale Bio Pipeline

Drug	Indication	Phase
Synecta™ Platform	Cell Therapy Manufacturing (Oncology focus)	Clinical Trial (partner-led)

Leadership Team at BlueWhale Bio

Chief Executive Officer

Pedro Moura, PhD

SVP, Head of Technology

Sr. Director, Marketing & Corporate Development

View full BlueWhale Bio profile